| 基金類型 | 跨國投資股票型全球市場 |
|---|---|
| 投資區域 | 全球 |
| 計價幣別 | 台幣 |
| 基金規模(億) | 105.72(2026/03/31) |
| 經理人 | 常李奕翰 |
| 基金 | 淨值 | 淨值日期 | 自成立日起 報酬率(%) |
自今年以來 報酬率(%) |
年化 標準差(%) |
Sharpe | Beta |
|---|---|---|---|---|---|---|---|
| 玉山全球醫療生化基金-累積型(台幣) | 51.6000 | 2026/04/27 | 416.00 | -7.71 | 22.63 | 0.16 | 0.25 |
| 個股名稱 | 比例 |
|---|---|
| UNITEDHEALTH GROUP INC | 5.4% |
| VERTEX PHARMACEUTICALS INC | 1.51% |
| MERCK & CO. INC. | 7.93% |
| UCB SA | 2.46% |
| ALIGN TECHNOLOGY INC | 1.57% |
| ELI LILLY & CO | 7.97% |
| LONZA GROUP AG-REG | 4.62% |
| TEVA PHARMACEUTICAL-SP ADR | 3.26% |
| BAYER AG-REG | 2.54% |
| DANAHER CORP | 4.55% |
| ASTRAZENECA PLC | 2.67% |
| Thermo Fisher Scientific Inc | 4.48% |
| GILEAD SCIENCES INC | 2.53% |
| REGENERON PHARMACEUTICALS | 1.27% |
| AGILENT TECHNOLOGIES INC | 3.1% |
| CVS Health Corp | 4.39% |
| EDWARDS LIFESCIENCES CORP | 2.8% |
| ARGENX SE | 1.36% |
| TANDEM DIABETES CARE INC | 1.12% |
| VAXCYTE INC | 3.08% |
| CRINETICS PHARMACEUTICALS IN | 2.32% |
| KYMERA THERAPEUTICS INC | 1.55% |
| TARSUS PHARMACEUTICALS INC | 2.06% |
| SCHOLAR ROCK HOLDING CORP | 1.53% |
| APOGEE THERAPEUTICS INC | 1.74% |
| NEWAMSTERDAM PHARMA CO NV | 1.29% |
| SIONNA THERAPEUTICS INC | 2.01% |
| LB PHARMACEUTICALS INC | 1.12% |
| PALVELLA THERAPEUTICS INC | 1.72% |